Patent Portfolio

Composition for target gene modification

Ref. No. AJ316
Appl. No.
(filing date)
PCT/JP2018/048034(2018/12/27)
Pub. No.
(Pub. date)
WO2019/131829(2019/7/4)
Priority claim No.
(Priority date)

JP2017-254798(2017/12/28)

Patent No.

EP3733844

Inventor HOTTA Akitsu, etc.
Assignee Kyoto University Takeda/Pharmaceutical Company Limited
Title of Invention Composition for target gene modification
Abstract

The present invention relates to a composition that allows the substance used in the CRISPR system to be introduced into cells as an active ingredient. Furthermore, the present invention relates to a method of inducing gene modification at a target locus in a cell using such a composition, for example, a method of preventing or treating muscular dystrophy by modifying the dystrophin gene of a muscle cell.

Information
(External link)
https://patents.google.com/patent/JPWO2019131829A1/en?oq=WO2019%2f131829
Tag